Valeant Former CEO Sues Company Over Unmade Payments
Michael Pearson, ex-CEO of Valeant Pharmaceuticals, is suing the embattled drugmaker for refusing to pay him more than 3 million company shares that he said he is owed. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Ryan Confident About Health Plan's Passage
Paul Ryan expressed confidence that the Republican health-care plan will pass the House later this week, saying his party’s lawmakers are working to make changes to the bill to address remaining concerns, including providing more assistance to older Americans. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 20, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
A Prescription Blood Thinner Beat Aspirin at Preventing Recurrence of Blood Clots, Study Finds
A Canadian research team found low doses of the blood thinner rivaroxaban, marketed as Xarelto from Johnson& Johnson unit Janssen Pharmaceuticals, reduced the risk of blood clot recurrence by about 70% compared with aspirin, without increasing the risk of bleeding. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 19, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Young People to Pay Less Under GOP Health Plan, CBO Says
A federal analysis of a Republican health plan that shows it would leave millions more uninsured has a silver lining for GOP leaders: In general, premiums under their proposal would eventually come down for younger people. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
GOP Senators Say House Health Bill Won't Pass Without Changes
Republican senators, alarmed by a nonpartisan report showing millions would lose insurance under the GOP health-care plan, warned Tuesday that the bill wouldn ’t become law without fundamental changes. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks
The benefits of an opioid painkiller linked to a 2015 HIV outbreak in Indiana no longer outweigh the risks, a panel of advisers to the U.S. Food and Drug Administration concluded Tuesday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
After CBO Report, Democrats See Opening on Health Care
Democrats, after playing defense on health care for nearly a decade, are trying to turn the issue to their advantage in next year ’s midterm elections, targeting in particular lawmakers who have already voted for the GOP health bill. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Generic Drugmakers Can Live With a Speedier FDA
FDA chief nominee Scott Gottlieb ’s changes may pressure generic drug prices, but there are other positives for the sector. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
AstraZeneca Gives Rejected Drugs a Second Life
AstraZeneca is working with outside researchers to look for untapped potential in drugs that the company has shelved, part of a broader move to improve its research-and-development output. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Pershing Square Sold Stake in Valeant
William Ackman ’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
CBO Sees 24 Million More Uninsured, $337 Billion Deficit Cut With GOP Plan
The number of Americans without health insurance would grow by 24 million under a House Republican proposal to topple most of the Affordable Care Act, according to a nonpartisan report that is likely to complicate GOP lawmakers ’ efforts to unite around the plan. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
After Record Year for Fatal Overdoses, New York City Targets Opioids
New York City will spend $38 million annually to combat an opioid epidemic that killed more than 1,000 New Yorkers last year, city officials said Monday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Seema Verma Confirmed as Head of Centers for Medicare and Medicaid Services
Seema Verma, President Donald Trump ’s pick to oversee the Medicare and Medicaid programs, won Senate confirmation in a largely party-line vote Monday, placing an advocate of overhauling Medicaid at the program’s helm. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
GOP Health Plan Would Hit Rural Areas Hard
The House Republican effort to overhaul the Affordable Care Act could hit many rural areas particularly hard, sharply increasing the cost for some residents buying their own insurance. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
GOP Health Plan Advances After Clearing Two Panels
Republicans in Congress scored a victory in their efforts to replace parts of the Affordable Care Act, pushing measures through two House committees. But opposition to the health overhaul remains strong. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
